"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients with obesity or overweight," the team explained in their paper.

In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not for nothing — a lot of people turned to this diabetes medicine with the hopes that it would help them lose weight — and it did.

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish pharmaceutical company has enacted a hiring freeze—the latest sign of a sinking financial outlook for the once-titan of the obesity treatment world.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.

Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur weight loss. A recent study found that about 4% of Americans took these meds last year.

Aisleyne Horgan Wallace (GMB) Ozempic is safe, “Fauxzempic” is not, goes the logic. But it is wrong to imagine the potential harms end there. Last year, the NHS’s medical director spoke out about the number of “otherwise healthy” users ending up ...

Influencer Tana Mongeau questioned if she had Ozempic vulva on TikTok, after reported side effect goes viral online.

America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight. The consequences are far from fluffy. Those extra pounds can lead to serious health issues, sky-high vet bills and fewer years with your furry friend.

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for Americans.